April 24, 2024
Fecal Calprotectin Test Market

The Rising Fecal Calprotectin Testing Market driven by Increasing IBD Prevalence Globally

The fecal calprotectin test market offers a non-invasive solution for detecting intestinal inflammation associated with inflammatory bowel disease (IBD). Fecal Calprotectin is a protein released by the immune system during inflammation in the intestines. The test helps physicians monitor and diagnose conditions like ulcerative colitis and Crohn’s disease in a more cost-effective way compared to invasive endoscopies. The Global Fecal Calprotectin Test Market is estimated to be valued at US$ 161.98 Mn in 2024 and is expected to exhibit a CAGR of 3.9% over the forecast period 2024 to 2030.

Fecal Calprotectin tests help detect intestinal inflammation and infections by measuring the level of Calprotectin in stool samples. Higher than normal levels indicate intestinal inflammation associated with IBD. The test provides an inexpensive and painless way to diagnosis IBD compared to endoscopies and colonoscopies. It can also help monitor the effectiveness of IBD treatments without repeated invasive procedures. The rising prevalence of IBD worldwide especially in developed nations is a major driver for the increasing demand of Fecal Calprotectin tests.

Global Fecal Calprotectin Testing Market is estimated to be valued at US$ 161.98 Mn in 2024 and is expected to exhibit a CAGR of 3.9% over the forecast period 2024 to 2030.

Key Takeaways

Key players operating in the Fecal Calprotectin testing market are John Deere, Vermeer Corporation, Kuhn Group, AGCO Corporation, Krone North America, New Holland Agriculture, Claas Group, Kubota Corporation, Fella Maschinenbau GmbH, Sitrex S.p.A., Deutz-Fahr, Enorossi, Tonutti, Galfre, Pottinger Agricultural Machinery.

The growing prevalence of IBD worldwide especially in developed nations is driving the demand for Fecal Calprotectin tests. Early diagnosis is crucial for effective IBD management and fecal Calprotectin tests are replacing expensive invasive tests as the primary diagnostic tool.

Major players are expanding their presence globally especially in emerging Asian and Latin American markets to tap the potential offered by increasing healthcare access and spending. Companies are also launching innovative user friendly collection and analysis systems to make Fecal Calprotectin testing more mainstream.

Market Key Trends

One of the key trends in the Fecal Calprotectin Testing Market Demand is the increasing focus on home based sample collection kits. Major players have launched user friendly at-home collection kits that can be easily shipped to testing laboratories. This allows patients to collect samples comfortably at home and doctors to monitor disease without visits to healthcare facilities reducing costs for both. At-home Fecal immunochemical tests (FITs) are expected to drive further market growth.

Porter’s Analysis

Threat of new entrants: Low barriers to entry makes it easy for new players to enter the market which may increase the competition faced by existing players.

Bargaining power of buyers: There exists moderate bargaining power of the buyers as they have limited number of options available in the market.

Bargaining power of suppliers: The suppliers have moderate bargaining power due to availability of substitutes and importance of quality raw materials.

Threat of new substitutes: Threat is moderate as there are limited substitutes available for fecal calprotectin test.

Competitive rivalry: Intense competition exists among existing players to gain market share.

Geographical Regions

North America accounts for the largest share of the global fecal calprotectin test market primarily due to increasing prevalence of inflammatory bowel disease in the region. Moreover, existence of major market players and availability of advanced healthcare infrastructure support market growth in North America.

Asia Pacific region is expected to grow at the fastest rate over the forecast period owing to rising disposable income, growing awareness regarding disease diagnosis and increasing healthcare expenditure in emerging countries such as China and India. Large patient pool and improving healthcare facilities in APAC countries provide growth opportunities for fecal calprotectin test market players.

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it